http://repository.usmf.md:80/handle/20.500.12710/24177 Sun, 12 Apr 2026 15:40:36 GMT 2026-04-12T15:40:36Z http://repository.usmf.md:80/handle/20.500.12710/24207 Title: Revista de Științe ale Sănătății din Moldova = Moldovan Journal of Health Sciences. 2022, Vol. 29(3) Abstract: Revista de Științe ale Sănătății din Moldova (Moldovan Journal of Health Sciences) a fost lansată în octombrie 2014. Aceasta este editată în limbile română și engleză, conform standardelor și ghidurilor internaționale actuale în domeniul științelor medicale, și are o apariție trimestrială. Revista este înregistrată în Instrumentul Bibliometric Național IBN/IDSI (nr.1 din 16.11.2015), iar din 21 decembrie 2017, prin Hotărârea Consiliului Suprem pentru Știință și Dezvoltare Tehnologică nr. 169, a fost inclusă în lista revistelor științifice de Tip B. Revista este înregistrată în 2 baze de date internaționale. Sat, 01 Jan 2022 00:00:00 GMT http://repository.usmf.md:80/handle/20.500.12710/24207 2022-01-01T00:00:00Z http://repository.usmf.md:80/handle/20.500.12710/24206 Title: Recovery of patients with gout Authors: Rotaru, Larisa; Groppa, Liliana; Popa, Serghei; Nurseitova, Tamilla; Cornea, Cornelia Abstract: Abstract. Introduction. The incidence and prevalence of gout have increased worldwide in recent decades. Scientists at the Rochester Epidemiology Project (MN, USA) have seen a two-fold increase in the incidence of primary gout (patients without diuretic exposure) over a 20-year period, which ended in 1996. The increase of incidence may be related due to the difficulty and often unsatisfactory treatment options. The aim of the study was to systematize the recommendations on dietary treatment, and medication for patients with gout. Materials and methods. An analytical, qualitative, and secondary study was performed in the form of a synthesis article. 115 sources were identified and analyzed; from this list, 44 sources were selected according to the impact score during the publication period and according to the level of recommendations. Results. 44 articles were included. Most studies were small, retrospective analyses performed in single centers, with concerns for bias. Eleven studies (including five randomized controlled trials) reported improved patient outcomes following pharmacological interventions with known efficacy in gout, including allopurinol, prednisolone, NSAIDs and anakinra. Eight studies reported improved outcomes associated with non-pharmacological interventions: inpatient rheumatology consultation and a hospital gout management protocol. No studies to date have prospectively evaluated strategies designed to prevent re-admissions of patients hospitalized for gout flares. Conclusions. Urate crystals is completely soluble when we can lower the serum level of uric acid to normal values, but this often requires long-term treatment. The early onset of rehabilitation of affected joints helps to reduce the articular inflammatory process, the pain syndrome and it delays the progression of the underlying pathology while improving the quality of life in patients with gout. Further research is needed to enable healthcare providers to individualize and optimize gout treatment strategies, ensuring that patients with gout receive effective, safe, and high-quality care. Sat, 01 Jan 2022 00:00:00 GMT http://repository.usmf.md:80/handle/20.500.12710/24206 2022-01-01T00:00:00Z http://repository.usmf.md:80/handle/20.500.12710/24204 Title: Impact of vitamin D in chronic kidney disease and its effect on the musculoskeletal system Authors: Groza, Costina; Groppa, Liliana; Popa, Serghei; Sasu, Dorian; Rotaru, Larisa Abstract: Abstract. Introduction. Vitamin D plays an important role in maintaining musculoskeletal health. As the glomerular filtration rate decreases, vitamin D deficiency also occurs. The aim of this paper is to highlight the level of vitamin D depending on the stage of chronic kidney disease. Materials and methods. A structured search was performed in the PubMed, Scopus and HINARI databases, where the relevant articles have been taken into account, published in the last 20 years. The search terms used (in English) were: „vitamin D deficiency”, „pathogenesis of vitamin D”, ”the impact of vitamin D in chronic kidney disease”, „chronic kidney disease”. Results. Several studies have shown that the change in vitamin D levels is dependent to the decrease of glomerular filtration rate. The lowest serum vitamin D concentration was observed in stage 5 of chronic kidney disease. Vitamin D deficiency occurs due to a decrease in the number of nephrons and a decrease in the number of proximal tubular cells that absorb vitamin D (25 (OH) D) to be subsequently hydroxylated to its active form by 1α-hydroxylase. Conclusions. Patients with vitamin D-deficient due to chronic kidney disease have an increased risk of decreased bone mineral density and multiple fractures. Sat, 01 Jan 2022 00:00:00 GMT http://repository.usmf.md:80/handle/20.500.12710/24204 2022-01-01T00:00:00Z http://repository.usmf.md:80/handle/20.500.12710/24202 Title: Molecular and cellular biomarkers in status epilepticus and epilepsy Authors: Calcîi, Cornelia; Hadjiu, Svetlana; Calistru, Iulia; Calistru, Andrei; Feghiu, Ludmila; Constantin, Olga; Groppa, Stanislav Abstract: Summary. Introduction. Peripheral biomarkers have numerous uses in the treatment, prognosis, and pharmacovigilance of epilepsy. Unfortunately, no peripheral biomarker has demonstrated proven efficacy, although several options are being investigated. In this article, we want to analyze the main areas in which peripheral biomarkers can present their usefulness, including participation in the processes of inflammation, dysfunction of the blood-brain barrier, changes in metabolism, hormones, and growth factors. Material and methods. Publications on diagnostic biomarkers of epilepsy were reviewed. References were identified by PubMed, MEDLINE and Scopus search until June 2022, with various combinations of the terms – „epilepsy”, „seizures”, „epileptogenesis”, „biomarkers”, „neuroimaging”, „inflammation”, „status epilepticus”, „prognosis”. A qualitative and analytical study was performed focused on primary studies published in 2020-2022. More than 85 sources were identified and 33 were selected for analysis from the PubMed, MEDLINE, and Scopus online databases. 12 articles, 5 clinical trials, 2 meta-analyses, 7 reviews, and 7 systematic reviews were identified. Results. Screening articles from online databases according to the search criteria, we found 258 titles on molecular and cellular biomarkers in epilepsy highlighted. The final bibliography included 33 sources that summarized that biomarkers of epileptogenesis are expensive and difficult to research, but the identification of biomarkers specific to the entire epileptogenic process, in close proximity to neuronal damage, have demonstrated the possibility of predicting the risk of seizures, epilepsy and resistance to treatment. Conclusions. Epilepsy remains a continuous area of research; a special role is occupied by specific biomarkers of great clinical importance, being necessary for the prognosis of the disease, the risk of neurological sequelae, refractory to anti-epileptic drugs. Thus, their identification could have a significant impact on the clinical course of the disease. Sat, 01 Jan 2022 00:00:00 GMT http://repository.usmf.md:80/handle/20.500.12710/24202 2022-01-01T00:00:00Z